Selected research
Market Structure
Global Fractionated Plasma Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Fractionated Plasma Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Fractionated Plasma Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fractionated Plasma Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fractionated Plasma Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Fractionated Plasma Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fractionated Plasma Products include Takeda, Weiguang Bio, Tiantan Bio, Hualan Bio, Yuanda Shuyang, Shuanglin Bio, RAAS, Octapharma and Nanyue Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Fractionated Plasma Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fractionated Plasma Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fractionated Plasma Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Fractionated Plasma Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Fractionated Plasma Products Segment by Company
Takeda
Weiguang Bio
Tiantan Bio
Hualan Bio
Yuanda Shuyang
Shuanglin Bio
RAAS
Octapharma
Nanyue Bio
LFB Group
KM Biologics
Kedrion
Grifols
CSL
CBPO
BPL
Boya Bio
Biotest
Fractionated Plasma Products Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Other
Fractionated Plasma Products Segment by Application
Immunology
Hematology
Other
Fractionated Plasma Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fractionated Plasma Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fractionated Plasma Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fractionated Plasma Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Fractionated Plasma Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fractionated Plasma Products industry.
Chapter 3: Detailed analysis of Fractionated Plasma Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fractionated Plasma Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Coagulation Factor
- Immune Globulin
- Albumin
- Other
Applications
- Immunology
- Hematology
- Other
Companies covered
- Takeda
- Weiguang Bio
- Tiantan Bio
- Hualan Bio
- Yuanda Shuyang
- Shuanglin Bio
- RAAS
- Octapharma
- Nanyue Bio
- LFB Group
- KM Biologics
- Kedrion
- Grifols
- CSL
- CBPO
- BPL
- Boya Bio
- Biotest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Fractionated Plasma Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Coagulation Factor
- 1.2.3 Immune Globulin
- 1.2.4 Albumin
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Fractionated Plasma Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Immunology
- 1.3.3 Hematology
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Fractionated Plasma Products Growth Trends by Region
- 1.5.1 Global Fractionated Plasma Products Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Fractionated Plasma Products Market Size by Region (2021-2026)
- 1.5.3 Fractionated Plasma Products Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Fractionated Plasma Products Market Dynamics
- 2.1 Fractionated Plasma Products Industry Trends
- 2.2 Fractionated Plasma Products Industry Drivers
- 2.3 Fractionated Plasma Products Industry Opportunities and Challenges
- 2.4 Fractionated Plasma Products Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Fractionated Plasma Products Revenue by Company (2021-2026)
- 3.2 Global Fractionated Plasma Products Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Fractionated Plasma Products Key Company Head office and Area Served
- 3.4 Global Fractionated Plasma Products Company, Product Type & Application
- 3.5 Global Fractionated Plasma Products Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Fractionated Plasma Products Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Fractionated Plasma Products Players Market Share by Revenue in 2025
- 3.6.3 2025 Fractionated Plasma Products Tier 1, Tier 2, and Tier 3
4 Fractionated Plasma Products Market by Type
- 4.1 Global Fractionated Plasma Products Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Fractionated Plasma Products Market Size by Type (2021-2032)
- 4.3 Global Fractionated Plasma Products Market Size Share by Type (2021-2032)
5 Fractionated Plasma Products Market by Application
- 5.1 Global Fractionated Plasma Products Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Fractionated Plasma Products Market Size by Application (2021-2032)
- 5.3 Global Fractionated Plasma Products Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Takeda Fractionated Plasma Products Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Weiguang Bio
- 6.2.1 Weiguang Bio Company Information
- 6.2.2 Weiguang Bio Business Overview
- 6.2.3 Weiguang Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Weiguang Bio Fractionated Plasma Products Product Portfolio
- 6.2.5 Weiguang Bio Recent Developments
- 6.3 Tiantan Bio
- 6.3.1 Tiantan Bio Company Information
- 6.3.2 Tiantan Bio Business Overview
- 6.3.3 Tiantan Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Tiantan Bio Fractionated Plasma Products Product Portfolio
- 6.3.5 Tiantan Bio Recent Developments
- 6.4 Hualan Bio
- 6.4.1 Hualan Bio Company Information
- 6.4.2 Hualan Bio Business Overview
- 6.4.3 Hualan Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Hualan Bio Fractionated Plasma Products Product Portfolio
- 6.4.5 Hualan Bio Recent Developments
- 6.5 Yuanda Shuyang
- 6.5.1 Yuanda Shuyang Company Information
- 6.5.2 Yuanda Shuyang Business Overview
- 6.5.3 Yuanda Shuyang Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Yuanda Shuyang Fractionated Plasma Products Product Portfolio
- 6.5.5 Yuanda Shuyang Recent Developments
- 6.6 Shuanglin Bio
- 6.6.1 Shuanglin Bio Company Information
- 6.6.2 Shuanglin Bio Business Overview
- 6.6.3 Shuanglin Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Shuanglin Bio Fractionated Plasma Products Product Portfolio
- 6.6.5 Shuanglin Bio Recent Developments
- 6.7 RAAS
- 6.7.1 RAAS Company Information
- 6.7.2 RAAS Business Overview
- 6.7.3 RAAS Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 RAAS Fractionated Plasma Products Product Portfolio
- 6.7.5 RAAS Recent Developments
- 6.8 Octapharma
- 6.8.1 Octapharma Company Information
- 6.8.2 Octapharma Business Overview
- 6.8.3 Octapharma Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Octapharma Fractionated Plasma Products Product Portfolio
- 6.8.5 Octapharma Recent Developments
- 6.9 Nanyue Bio
- 6.9.1 Nanyue Bio Company Information
- 6.9.2 Nanyue Bio Business Overview
- 6.9.3 Nanyue Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Nanyue Bio Fractionated Plasma Products Product Portfolio
- 6.9.5 Nanyue Bio Recent Developments
- 6.10 LFB Group
- 6.10.1 LFB Group Company Information
- 6.10.2 LFB Group Business Overview
- 6.10.3 LFB Group Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 LFB Group Fractionated Plasma Products Product Portfolio
- 6.10.5 LFB Group Recent Developments
- 6.11 KM Biologics
- 6.11.1 KM Biologics Company Information
- 6.11.2 KM Biologics Business Overview
- 6.11.3 KM Biologics Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 KM Biologics Fractionated Plasma Products Product Portfolio
- 6.11.5 KM Biologics Recent Developments
- 6.12 Kedrion
- 6.12.1 Kedrion Company Information
- 6.12.2 Kedrion Business Overview
- 6.12.3 Kedrion Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Kedrion Fractionated Plasma Products Product Portfolio
- 6.12.5 Kedrion Recent Developments
- 6.13 Grifols
- 6.13.1 Grifols Company Information
- 6.13.2 Grifols Business Overview
- 6.13.3 Grifols Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Grifols Fractionated Plasma Products Product Portfolio
- 6.13.5 Grifols Recent Developments
- 6.14 CSL
- 6.14.1 CSL Company Information
- 6.14.2 CSL Business Overview
- 6.14.3 CSL Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 CSL Fractionated Plasma Products Product Portfolio
- 6.14.5 CSL Recent Developments
- 6.15 CBPO
- 6.15.1 CBPO Company Information
- 6.15.2 CBPO Business Overview
- 6.15.3 CBPO Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 CBPO Fractionated Plasma Products Product Portfolio
- 6.15.5 CBPO Recent Developments
- 6.16 BPL
- 6.16.1 BPL Company Information
- 6.16.2 BPL Business Overview
- 6.16.3 BPL Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 BPL Fractionated Plasma Products Product Portfolio
- 6.16.5 BPL Recent Developments
- 6.17 Boya Bio
- 6.17.1 Boya Bio Company Information
- 6.17.2 Boya Bio Business Overview
- 6.17.3 Boya Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Boya Bio Fractionated Plasma Products Product Portfolio
- 6.17.5 Boya Bio Recent Developments
- 6.18 Biotest
- 6.18.1 Biotest Company Information
- 6.18.2 Biotest Business Overview
- 6.18.3 Biotest Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Biotest Fractionated Plasma Products Product Portfolio
- 6.18.5 Biotest Recent Developments
7 North America
- 7.1 North America Fractionated Plasma Products Market Size (2021-2032)
- 7.2 North America Fractionated Plasma Products Market Size by Type
- 7.2.1 North America Fractionated Plasma Products Market Size by Type (2021-2026)
- 7.2.2 North America Fractionated Plasma Products Market Size by Type (2027-2032)
- 7.2.3 North America Fractionated Plasma Products Market Share by Type (2021-2032)
- 7.3 North America Fractionated Plasma Products Market Size by Application
- 7.3.1 North America Fractionated Plasma Products Market Size by Application (2021-2026)
- 7.3.2 North America Fractionated Plasma Products Market Size by Application (2027-2032)
- 7.3.3 North America Fractionated Plasma Products Market Share by Application (2021-2032)
- 7.4 North America Fractionated Plasma Products Market Size by Country
- 7.4.1 North America Fractionated Plasma Products Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Fractionated Plasma Products Market Size by Country (2021-2026)
- 7.4.3 North America Fractionated Plasma Products Market Size by Country (2027-2032)
- 7.4.4 North America Fractionated Plasma Products Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Fractionated Plasma Products Market Size (2021-2032)
- 8.2 Europe Fractionated Plasma Products Market Size by Type
- 8.2.1 Europe Fractionated Plasma Products Market Size by Type (2021-2026)
- 8.2.2 Europe Fractionated Plasma Products Market Size by Type (2027-2032)
- 8.2.3 Europe Fractionated Plasma Products Market Share by Type (2021-2032)
- 8.3 Europe Fractionated Plasma Products Market Size by Application
- 8.3.1 Europe Fractionated Plasma Products Market Size by Application (2021-2026)
- 8.3.2 Europe Fractionated Plasma Products Market Size by Application (2027-2032)
- 8.3.3 Europe Fractionated Plasma Products Market Share by Application (2021-2032)
- 8.4 Europe Fractionated Plasma Products Market Size by Country
- 8.4.1 Europe Fractionated Plasma Products Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Fractionated Plasma Products Market Size by Country (2021-2026)
- 8.4.3 Europe Fractionated Plasma Products Market Size by Country (2027-2032)
- 8.4.4 Europe Fractionated Plasma Products Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Fractionated Plasma Products Market Size (2021-2032)
- 9.2 China Fractionated Plasma Products Market Size by Type
- 9.2.1 China Fractionated Plasma Products Market Size by Type (2021-2026)
- 9.2.2 China Fractionated Plasma Products Market Size by Type (2027-2032)
- 9.2.3 China Fractionated Plasma Products Market Share by Type (2021-2032)
- 9.3 China Fractionated Plasma Products Market Size by Application
- 9.3.1 China Fractionated Plasma Products Market Size by Application (2021-2026)
- 9.3.2 China Fractionated Plasma Products Market Size by Application (2027-2032)
- 9.3.3 China Fractionated Plasma Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Fractionated Plasma Products Market Size (2021-2032)
- 10.2 Asia Fractionated Plasma Products Market Size by Type
- 10.2.1 Asia Fractionated Plasma Products Market Size by Type (2021-2026)
- 10.2.2 Asia Fractionated Plasma Products Market Size by Type (2027-2032)
- 10.2.3 Asia Fractionated Plasma Products Market Share by Type (2021-2032)
- 10.3 Asia Fractionated Plasma Products Market Size by Application
- 10.3.1 Asia Fractionated Plasma Products Market Size by Application (2021-2026)
- 10.3.2 Asia Fractionated Plasma Products Market Size by Application (2027-2032)
- 10.3.3 Asia Fractionated Plasma Products Market Share by Application (2021-2032)
- 10.4 Asia Fractionated Plasma Products Market Size by Country
- 10.4.1 Asia Fractionated Plasma Products Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Fractionated Plasma Products Market Size by Country (2021-2026)
- 10.4.3 Asia Fractionated Plasma Products Market Size by Country (2027-2032)
- 10.4.4 Asia Fractionated Plasma Products Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Fractionated Plasma Products Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Fractionated Plasma Products Market Size by Type
- 11.2.1 South America, Middle East & Africa Fractionated Plasma Products Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Fractionated Plasma Products Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Fractionated Plasma Products Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Fractionated Plasma Products Market Size by Application
- 11.3.1 South America, Middle East & Africa Fractionated Plasma Products Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Fractionated Plasma Products Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Fractionated Plasma Products Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Fractionated Plasma Products Market Size by Country
- 11.4.1 South America, Middle East & Africa Fractionated Plasma Products Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Fractionated Plasma Products Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Fractionated Plasma Products Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Fractionated Plasma Products Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst